Literature DB >> 25619264

Expression of NK cell and monocyte receptors in critically ill patients--potential biomarkers of sepsis.

A G Kjaergaard1, J S Nielsen, E Tønnesen, J Krog.   

Abstract

UNLABELLED: Sepsis is characterized by activation of both the innate and adaptive immune systems as a response to infection. During sepsis, the expression of surface receptors expressed on immune competent cells, such as NKG2D and NKp30 on NK cells and TLR4 and CD14 on monocytes, is partly regulated by pro- and anti-inflammatory mediators. In this observational study, we aimed to explore whether the expression of these receptors could be used as diagnostic and/or prognostic biomarkers in sepsis. Patients with severe sepsis or septic shock (n = 21) were compared with critically ill non-septic patients (n = 15). Healthy volunteers (n = 15) served as controls. To elucidate variations over time, all patients were followed for 4 days. Cell surface expression of NKG2D, NKp30, TLR4 and CD14 and serum levels of IL-1β, IL-6, IFN-γ, TNF-α, IL-4 and IL-10 was estimated by flow cytometry. We found that NK cell expression of NKG2D and monocyte expression of CD14 were lower in the septic patients compared with the non-septic patients, both at ICU admission and during the observation period (P < 0.01 for all comparisons). Both at ICU admission, and during the observation period, levels of IL-6 and IL-10 were higher in the septic patients compared with the non-septic patients (P < 0.001 for all comparisons).
CONCLUSION: As both NKG2D and CD14 levels appear to distinguish between septic and non-septic patients, both NKG2D and CD14 may be considered potential diagnostic biomarkers of severe sepsis and septic shock.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25619264     DOI: 10.1111/sji.12272

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

Review 1.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925

Review 2.  IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.

Authors:  Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

Review 3.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

4.  Effect of Immune-Enhancing Enteral Nutrition Enriched with or without Beta-Glucan on Immunomodulation in Critically Ill Patients.

Authors:  Jae Gil Lee; Young Sam Kim; Young Ju Lee; Hyeon Yeong Ahn; Minjoo Kim; Minkyung Kim; Min Jung Cho; Younsoo Cho; Jong Ho Lee
Journal:  Nutrients       Date:  2016-06-02       Impact factor: 5.717

5.  Hyporesponsiveness of natural killer cells and impaired inflammatory responses in critically ill patients.

Authors:  Minkyung Kim; Minjoo Kim; Hana Jeong; Jey Sook Chae; Young Sam Kim; Jae Gil Lee; Younsoo Cho; Jong Ho Lee
Journal:  BMC Immunol       Date:  2017-12-08       Impact factor: 3.615

6.  Increased percentage of PD-L1+ natural killer cells predicts poor prognosis in sepsis patients: a prospective observational cohort study.

Authors:  Wenqiang Jiang; Xusheng Li; Miaoyun Wen; Xiaoyu Liu; Kangrong Wang; Qiaosheng Wang; Ya Li; Maohua Zhou; Mengting Liu; Bei Hu; Hongke Zeng
Journal:  Crit Care       Date:  2020-10-19       Impact factor: 9.097

Review 7.  The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.

Authors:  Jillian Poles; Elisa Karhu; Megan McGill; H Reginald McDaniel; John E Lewis
Journal:  J Clin Transl Res       Date:  2021-05-27

Review 8.  Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

Review 9.  Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities?

Authors:  Ivana Plavsic; Ivana Žitinić; Ivana Mikolasevic; Goran Poropat; Goran Hauser
Journal:  World J Gastrointest Endosc       Date:  2018-10-16

10.  Effect of immune-enhancing enteral nutrition formula enriched with plant-derived n-3 fatty acids on natural killer cell activity in rehabilitation patients.

Authors:  Jung Min Cho; Hyo Seon Choi; Youn Soo Cho; So Young Park; Deog Young Kim; Jong Ho Lee
Journal:  Nutr Res Pract       Date:  2019-07-10       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.